Curaleaf Holdings (CURL.F) Stock Overview
Engages in the retail and wholesale of cannabis products in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
CURL.F Community Fair Values
Create NarrativeSee what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Curaleaf Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$9.99 |
| 52 Week High | CA$15.15 |
| 52 Week Low | CA$5.40 |
| Beta | 1.63 |
| 1 Month Change | 8.00% |
| 3 Month Change | 0.30% |
| 1 Year Change | 18.09% |
| 3 Year Change | 14.83% |
| 5 Year Change | -72.46% |
| Change since IPO | -49.23% |
Recent News & Updates
CURL.F: Share Repurchases And New Dispensaries Will Support Future Upside
Analysts have raised their price target for Curaleaf Holdings from about $12.50 to about $13.21, citing updated assumptions around revenue growth, profit margins, and future P/E expectations. What’s in the News for Curaleaf Holdings Curaleaf Holdings completed a share repurchase tranche between April 16, 2026 and June 30, 2026, buying back 93,363 shares for about C$1 million, equal to about 0.04% of shares outstanding.CURL.D: Share Repurchase Will Support Future Upside Despite Lower P/E Assumptions
Analysts have adjusted their price target on Curaleaf Holdings from $15.00 to about $12.50, citing updated fair value estimates that take into account revised profit margin assumptions and a lower projected future P/E multiple. What’s in the News for Curaleaf Holdings Curaleaf Holdings shareholders approved an amendment to the company’s articles at the June 22, 2026 annual general and special meeting, removing the automatic conversion feature of the Multiple Voting Shares following a potential listing of Subordinate Voting Shares on a major U.S. exchange.Recent updates
CURL.F: Share Repurchases And New Dispensaries Will Support Future Upside
Analysts have raised their price target for Curaleaf Holdings from about $12.50 to about $13.21, citing updated assumptions around revenue growth, profit margins, and future P/E expectations. What’s in the News for Curaleaf Holdings Curaleaf Holdings completed a share repurchase tranche between April 16, 2026 and June 30, 2026, buying back 93,363 shares for about C$1 million, equal to about 0.04% of shares outstanding.CURL.D: Share Repurchase Will Support Future Upside Despite Lower P/E Assumptions
Analysts have adjusted their price target on Curaleaf Holdings from $15.00 to about $12.50, citing updated fair value estimates that take into account revised profit margin assumptions and a lower projected future P/E multiple. What’s in the News for Curaleaf Holdings Curaleaf Holdings shareholders approved an amendment to the company’s articles at the June 22, 2026 annual general and special meeting, removing the automatic conversion feature of the Multiple Voting Shares following a potential listing of Subordinate Voting Shares on a major U.S. exchange.Rescheduling And International Expansion Will Reshape This Vertically Integrated Cannabis Operator
Catalysts About Curaleaf Holdings Curaleaf Holdings operates a vertically integrated cannabis business across U.S. and international medical and adult use markets. What are the underlying business or industry changes driving this perspective?Shareholder Returns
| CURL.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 5.5% | 5.8% | -1.5% |
| 1Y | 18.1% | 55.9% | 17.8% |
Return vs Industry: CURL.F underperformed the US Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: CURL.F matched the US Market which returned 17.8% over the past year.
Price Volatility
| CURL.F volatility | |
|---|---|
| CURL.F Average Weekly Movement | 9.2% |
| Pharmaceuticals Industry Average Movement | 9.2% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CURL.F has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CURL.F's weekly volatility has decreased from 16% to 9% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 5,554 | Boris Jordan | www.curaleaf.com |
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway.
Curaleaf Holdings, Inc. Fundamentals Summary
| CURL.F fundamental statistics | |
|---|---|
| Market cap | US$2.64b |
| Earnings (TTM) | -US$41.20m |
| Revenue (TTM) | US$1.32b |
Is CURL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CURL.F income statement (TTM) | |
|---|---|
| Revenue | US$1.32b |
| Cost of Revenue | US$665.68m |
| Gross Profit | US$649.58m |
| Other Expenses | US$690.78m |
| Earnings | -US$41.20m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.16 |
| Gross Margin | 49.39% |
| Net Profit Margin | -3.13% |
| Debt/Equity Ratio | 94.2% |
How did CURL.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/23 03:15 |
| End of Day Share Price | 2026/08/21 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Curaleaf Holdings, Inc. is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Kenric Tyghe | Canaccord Genuity |